nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—HTR2A—hindlimb—muscle cancer	0.00284	0.0781	CbGeAlD
Paliperidone—HTR2A—appendage—muscle cancer	0.00244	0.067	CbGeAlD
Paliperidone—DRD4—testis—muscle cancer	0.00202	0.0555	CbGeAlD
Paliperidone—Decreased appetite—Vincristine—muscle cancer	0.00177	0.00184	CcSEcCtD
Paliperidone—Cough—Etoposide—muscle cancer	0.00177	0.00183	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Vincristine—muscle cancer	0.00176	0.00183	CcSEcCtD
Paliperidone—Fatigue—Vincristine—muscle cancer	0.00176	0.00182	CcSEcCtD
Paliperidone—Convulsion—Etoposide—muscle cancer	0.00175	0.00182	CcSEcCtD
Paliperidone—Hypertension—Etoposide—muscle cancer	0.00175	0.00181	CcSEcCtD
Paliperidone—Constipation—Vincristine—muscle cancer	0.00174	0.00181	CcSEcCtD
Paliperidone—Pain—Vincristine—muscle cancer	0.00174	0.00181	CcSEcCtD
Paliperidone—Osteoarthritis—Doxorubicin—muscle cancer	0.00174	0.00181	CcSEcCtD
Paliperidone—Pain in extremity—Doxorubicin—muscle cancer	0.00174	0.00181	CcSEcCtD
Paliperidone—Chest pain—Etoposide—muscle cancer	0.00172	0.00179	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00171	0.00178	CcSEcCtD
Paliperidone—Pancreatitis—Methotrexate—muscle cancer	0.00171	0.00177	CcSEcCtD
Paliperidone—Discomfort—Etoposide—muscle cancer	0.0017	0.00177	CcSEcCtD
Paliperidone—ADRA1B—renal system—muscle cancer	0.00169	0.0464	CbGeAlD
Paliperidone—Face oedema—Doxorubicin—muscle cancer	0.00168	0.00175	CcSEcCtD
Paliperidone—Hypersensitivity—Dactinomycin—muscle cancer	0.00168	0.00174	CcSEcCtD
Paliperidone—Abdominal discomfort—Methotrexate—muscle cancer	0.00167	0.00173	CcSEcCtD
Paliperidone—Gastrointestinal pain—Vincristine—muscle cancer	0.00167	0.00173	CcSEcCtD
Paliperidone—Confusional state—Etoposide—muscle cancer	0.00167	0.00173	CcSEcCtD
Paliperidone—Cardiac arrest—Doxorubicin—muscle cancer	0.00166	0.00172	CcSEcCtD
Paliperidone—Anaphylactic shock—Etoposide—muscle cancer	0.00165	0.00171	CcSEcCtD
Paliperidone—Infection—Etoposide—muscle cancer	0.00164	0.0017	CcSEcCtD
Paliperidone—Asthenia—Dactinomycin—muscle cancer	0.00164	0.0017	CcSEcCtD
Paliperidone—Dysuria—Methotrexate—muscle cancer	0.00163	0.00169	CcSEcCtD
Paliperidone—Neutropenia—Methotrexate—muscle cancer	0.00163	0.00169	CcSEcCtD
Paliperidone—Thrombocytopenia—Etoposide—muscle cancer	0.00162	0.00168	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00162	0.00168	CcSEcCtD
Paliperidone—Tachycardia—Etoposide—muscle cancer	0.00161	0.00167	CcSEcCtD
Paliperidone—Abdominal pain—Vincristine—muscle cancer	0.00161	0.00167	CcSEcCtD
Paliperidone—Body temperature increased—Vincristine—muscle cancer	0.00161	0.00167	CcSEcCtD
Paliperidone—Skin disorder—Etoposide—muscle cancer	0.0016	0.00166	CcSEcCtD
Paliperidone—Erectile dysfunction—Methotrexate—muscle cancer	0.0016	0.00166	CcSEcCtD
Paliperidone—Dry skin—Doxorubicin—muscle cancer	0.0016	0.00166	CcSEcCtD
Paliperidone—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00159	0.00165	CcSEcCtD
Paliperidone—Abdominal pain upper—Doxorubicin—muscle cancer	0.00159	0.00165	CcSEcCtD
Paliperidone—Breast disorder—Doxorubicin—muscle cancer	0.00157	0.00163	CcSEcCtD
Paliperidone—Anorexia—Etoposide—muscle cancer	0.00157	0.00163	CcSEcCtD
Paliperidone—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00157	0.00163	CcSEcCtD
Paliperidone—Diarrhoea—Dactinomycin—muscle cancer	0.00156	0.00162	CcSEcCtD
Paliperidone—Pneumonia—Methotrexate—muscle cancer	0.00156	0.00162	CcSEcCtD
Paliperidone—Nasopharyngitis—Doxorubicin—muscle cancer	0.00156	0.00162	CcSEcCtD
Paliperidone—Infestation NOS—Methotrexate—muscle cancer	0.00155	0.00161	CcSEcCtD
Paliperidone—Infestation—Methotrexate—muscle cancer	0.00155	0.00161	CcSEcCtD
Paliperidone—Depression—Methotrexate—muscle cancer	0.00155	0.0016	CcSEcCtD
Paliperidone—Hypotension—Etoposide—muscle cancer	0.00154	0.0016	CcSEcCtD
Paliperidone—Muscular weakness—Doxorubicin—muscle cancer	0.00154	0.0016	CcSEcCtD
Paliperidone—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00154	0.0016	CcSEcCtD
Paliperidone—Conjunctivitis—Methotrexate—muscle cancer	0.00151	0.00156	CcSEcCtD
Paliperidone—Dysphagia—Doxorubicin—muscle cancer	0.00151	0.00156	CcSEcCtD
Paliperidone—Influenza—Doxorubicin—muscle cancer	0.00151	0.00156	CcSEcCtD
Paliperidone—Hypersensitivity—Vincristine—muscle cancer	0.0015	0.00156	CcSEcCtD
Paliperidone—Paraesthesia—Etoposide—muscle cancer	0.00148	0.00154	CcSEcCtD
Paliperidone—Pancreatitis—Doxorubicin—muscle cancer	0.00148	0.00153	CcSEcCtD
Paliperidone—Dyspnoea—Etoposide—muscle cancer	0.00147	0.00153	CcSEcCtD
Paliperidone—DRD3—head—muscle cancer	0.00147	0.0404	CbGeAlD
Paliperidone—Somnolence—Etoposide—muscle cancer	0.00147	0.00152	CcSEcCtD
Paliperidone—Hepatobiliary disease—Methotrexate—muscle cancer	0.00147	0.00152	CcSEcCtD
Paliperidone—Epistaxis—Methotrexate—muscle cancer	0.00146	0.00152	CcSEcCtD
Paliperidone—Asthenia—Vincristine—muscle cancer	0.00146	0.00152	CcSEcCtD
Paliperidone—Vomiting—Dactinomycin—muscle cancer	0.00145	0.00151	CcSEcCtD
Paliperidone—Bronchitis—Doxorubicin—muscle cancer	0.00145	0.0015	CcSEcCtD
Paliperidone—Agranulocytosis—Methotrexate—muscle cancer	0.00145	0.0015	CcSEcCtD
Paliperidone—Rash—Dactinomycin—muscle cancer	0.00144	0.00149	CcSEcCtD
Paliperidone—Decreased appetite—Etoposide—muscle cancer	0.00144	0.00149	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Etoposide—muscle cancer	0.00143	0.00148	CcSEcCtD
Paliperidone—Fatigue—Etoposide—muscle cancer	0.00142	0.00148	CcSEcCtD
Paliperidone—Constipation—Etoposide—muscle cancer	0.00141	0.00147	CcSEcCtD
Paliperidone—Pain—Etoposide—muscle cancer	0.00141	0.00147	CcSEcCtD
Paliperidone—Dysuria—Doxorubicin—muscle cancer	0.00141	0.00146	CcSEcCtD
Paliperidone—Neutropenia—Doxorubicin—muscle cancer	0.00141	0.00146	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.0014	0.00145	CcSEcCtD
Paliperidone—Diarrhoea—Vincristine—muscle cancer	0.00139	0.00145	CcSEcCtD
Paliperidone—Pollakiuria—Doxorubicin—muscle cancer	0.00139	0.00144	CcSEcCtD
Paliperidone—Urinary tract disorder—Methotrexate—muscle cancer	0.00137	0.00143	CcSEcCtD
Paliperidone—Weight increased—Doxorubicin—muscle cancer	0.00137	0.00142	CcSEcCtD
Paliperidone—Urethral disorder—Methotrexate—muscle cancer	0.00136	0.00142	CcSEcCtD
Paliperidone—Weight decreased—Doxorubicin—muscle cancer	0.00136	0.00141	CcSEcCtD
Paliperidone—Feeling abnormal—Etoposide—muscle cancer	0.00136	0.00141	CcSEcCtD
Paliperidone—Hyperglycaemia—Doxorubicin—muscle cancer	0.00136	0.00141	CcSEcCtD
Paliperidone—Nausea—Dactinomycin—muscle cancer	0.00136	0.00141	CcSEcCtD
Paliperidone—Pneumonia—Doxorubicin—muscle cancer	0.00135	0.0014	CcSEcCtD
Paliperidone—Gastrointestinal pain—Etoposide—muscle cancer	0.00135	0.0014	CcSEcCtD
Paliperidone—Dizziness—Vincristine—muscle cancer	0.00135	0.0014	CcSEcCtD
Paliperidone—Infestation NOS—Doxorubicin—muscle cancer	0.00134	0.00139	CcSEcCtD
Paliperidone—Infestation—Doxorubicin—muscle cancer	0.00134	0.00139	CcSEcCtD
Paliperidone—Urticaria—Etoposide—muscle cancer	0.00131	0.00136	CcSEcCtD
Paliperidone—Jaundice—Doxorubicin—muscle cancer	0.00131	0.00136	CcSEcCtD
Paliperidone—Abdominal pain—Etoposide—muscle cancer	0.00131	0.00135	CcSEcCtD
Paliperidone—Body temperature increased—Etoposide—muscle cancer	0.00131	0.00135	CcSEcCtD
Paliperidone—Conjunctivitis—Doxorubicin—muscle cancer	0.00131	0.00135	CcSEcCtD
Paliperidone—Urinary tract infection—Doxorubicin—muscle cancer	0.00131	0.00135	CcSEcCtD
Paliperidone—Eye disorder—Methotrexate—muscle cancer	0.0013	0.00135	CcSEcCtD
Paliperidone—Tinnitus—Methotrexate—muscle cancer	0.0013	0.00135	CcSEcCtD
Paliperidone—Vomiting—Vincristine—muscle cancer	0.0013	0.00135	CcSEcCtD
Paliperidone—Cardiac disorder—Methotrexate—muscle cancer	0.00129	0.00134	CcSEcCtD
Paliperidone—Rash—Vincristine—muscle cancer	0.00129	0.00133	CcSEcCtD
Paliperidone—Dermatitis—Vincristine—muscle cancer	0.00128	0.00133	CcSEcCtD
Paliperidone—Headache—Vincristine—muscle cancer	0.00128	0.00133	CcSEcCtD
Paliperidone—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00127	0.00132	CcSEcCtD
Paliperidone—Epistaxis—Doxorubicin—muscle cancer	0.00127	0.00131	CcSEcCtD
Paliperidone—Angiopathy—Methotrexate—muscle cancer	0.00126	0.00131	CcSEcCtD
Paliperidone—Sinusitis—Doxorubicin—muscle cancer	0.00126	0.00131	CcSEcCtD
Paliperidone—Immune system disorder—Methotrexate—muscle cancer	0.00126	0.00131	CcSEcCtD
Paliperidone—Mediastinal disorder—Methotrexate—muscle cancer	0.00125	0.0013	CcSEcCtD
Paliperidone—Agranulocytosis—Doxorubicin—muscle cancer	0.00125	0.0013	CcSEcCtD
Paliperidone—Chills—Methotrexate—muscle cancer	0.00125	0.0013	CcSEcCtD
Paliperidone—Alopecia—Methotrexate—muscle cancer	0.00123	0.00128	CcSEcCtD
Paliperidone—Bradycardia—Doxorubicin—muscle cancer	0.00123	0.00127	CcSEcCtD
Paliperidone—Mental disorder—Methotrexate—muscle cancer	0.00122	0.00127	CcSEcCtD
Paliperidone—Hypersensitivity—Etoposide—muscle cancer	0.00122	0.00126	CcSEcCtD
Paliperidone—Erythema—Methotrexate—muscle cancer	0.00121	0.00126	CcSEcCtD
Paliperidone—Malnutrition—Methotrexate—muscle cancer	0.00121	0.00126	CcSEcCtD
Paliperidone—Nausea—Vincristine—muscle cancer	0.00121	0.00126	CcSEcCtD
Paliperidone—Rhinitis—Doxorubicin—muscle cancer	0.00121	0.00125	CcSEcCtD
Paliperidone—Hypoaesthesia—Doxorubicin—muscle cancer	0.0012	0.00124	CcSEcCtD
Paliperidone—Urinary tract disorder—Doxorubicin—muscle cancer	0.00119	0.00124	CcSEcCtD
Paliperidone—Oedema peripheral—Doxorubicin—muscle cancer	0.00119	0.00123	CcSEcCtD
Paliperidone—Dysgeusia—Methotrexate—muscle cancer	0.00119	0.00123	CcSEcCtD
Paliperidone—Asthenia—Etoposide—muscle cancer	0.00118	0.00123	CcSEcCtD
Paliperidone—Connective tissue disorder—Doxorubicin—muscle cancer	0.00118	0.00123	CcSEcCtD
Paliperidone—Urethral disorder—Doxorubicin—muscle cancer	0.00118	0.00123	CcSEcCtD
Paliperidone—Back pain—Methotrexate—muscle cancer	0.00117	0.00122	CcSEcCtD
Paliperidone—Pruritus—Etoposide—muscle cancer	0.00117	0.00121	CcSEcCtD
Paliperidone—Vision blurred—Methotrexate—muscle cancer	0.00114	0.00119	CcSEcCtD
Paliperidone—Diarrhoea—Etoposide—muscle cancer	0.00113	0.00117	CcSEcCtD
Paliperidone—ADRA1B—head—muscle cancer	0.00113	0.031	CbGeAlD
Paliperidone—Eye disorder—Doxorubicin—muscle cancer	0.00113	0.00117	CcSEcCtD
Paliperidone—Ill-defined disorder—Methotrexate—muscle cancer	0.00112	0.00117	CcSEcCtD
Paliperidone—Tinnitus—Doxorubicin—muscle cancer	0.00112	0.00117	CcSEcCtD
Paliperidone—Anaemia—Methotrexate—muscle cancer	0.00112	0.00116	CcSEcCtD
Paliperidone—Flushing—Doxorubicin—muscle cancer	0.00112	0.00116	CcSEcCtD
Paliperidone—Cardiac disorder—Doxorubicin—muscle cancer	0.00112	0.00116	CcSEcCtD
Paliperidone—Angiopathy—Doxorubicin—muscle cancer	0.00109	0.00114	CcSEcCtD
Paliperidone—Malaise—Methotrexate—muscle cancer	0.00109	0.00113	CcSEcCtD
Paliperidone—Dizziness—Etoposide—muscle cancer	0.00109	0.00113	CcSEcCtD
Paliperidone—Immune system disorder—Doxorubicin—muscle cancer	0.00109	0.00113	CcSEcCtD
Paliperidone—Vertigo—Methotrexate—muscle cancer	0.00109	0.00113	CcSEcCtD
Paliperidone—Mediastinal disorder—Doxorubicin—muscle cancer	0.00109	0.00113	CcSEcCtD
Paliperidone—Leukopenia—Methotrexate—muscle cancer	0.00108	0.00113	CcSEcCtD
Paliperidone—Chills—Doxorubicin—muscle cancer	0.00108	0.00112	CcSEcCtD
Paliperidone—Alopecia—Doxorubicin—muscle cancer	0.00107	0.00111	CcSEcCtD
Paliperidone—Cough—Methotrexate—muscle cancer	0.00106	0.0011	CcSEcCtD
Paliperidone—Mental disorder—Doxorubicin—muscle cancer	0.00106	0.0011	CcSEcCtD
Paliperidone—DRD1—head—muscle cancer	0.00105	0.0289	CbGeAlD
Paliperidone—Convulsion—Methotrexate—muscle cancer	0.00105	0.00109	CcSEcCtD
Paliperidone—Vomiting—Etoposide—muscle cancer	0.00105	0.00109	CcSEcCtD
Paliperidone—Malnutrition—Doxorubicin—muscle cancer	0.00105	0.00109	CcSEcCtD
Paliperidone—Erythema—Doxorubicin—muscle cancer	0.00105	0.00109	CcSEcCtD
Paliperidone—Rash—Etoposide—muscle cancer	0.00104	0.00108	CcSEcCtD
Paliperidone—Dermatitis—Etoposide—muscle cancer	0.00104	0.00108	CcSEcCtD
Paliperidone—Headache—Etoposide—muscle cancer	0.00103	0.00107	CcSEcCtD
Paliperidone—Flatulence—Doxorubicin—muscle cancer	0.00103	0.00107	CcSEcCtD
Paliperidone—Arthralgia—Methotrexate—muscle cancer	0.00103	0.00107	CcSEcCtD
Paliperidone—Myalgia—Methotrexate—muscle cancer	0.00103	0.00107	CcSEcCtD
Paliperidone—Chest pain—Methotrexate—muscle cancer	0.00103	0.00107	CcSEcCtD
Paliperidone—Tension—Doxorubicin—muscle cancer	0.00103	0.00107	CcSEcCtD
Paliperidone—HTR1A—renal system—muscle cancer	0.00103	0.0283	CbGeAlD
Paliperidone—Dysgeusia—Doxorubicin—muscle cancer	0.00103	0.00107	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00102	0.00106	CcSEcCtD
Paliperidone—Discomfort—Methotrexate—muscle cancer	0.00102	0.00106	CcSEcCtD
Paliperidone—Nervousness—Doxorubicin—muscle cancer	0.00102	0.00106	CcSEcCtD
Paliperidone—Back pain—Doxorubicin—muscle cancer	0.00102	0.00105	CcSEcCtD
Paliperidone—Muscle spasms—Doxorubicin—muscle cancer	0.00101	0.00105	CcSEcCtD
Paliperidone—Confusional state—Methotrexate—muscle cancer	0.000997	0.00104	CcSEcCtD
Paliperidone—Anaphylactic shock—Methotrexate—muscle cancer	0.000989	0.00103	CcSEcCtD
Paliperidone—Vision blurred—Doxorubicin—muscle cancer	0.000989	0.00103	CcSEcCtD
Paliperidone—Infection—Methotrexate—muscle cancer	0.000983	0.00102	CcSEcCtD
Paliperidone—Nausea—Etoposide—muscle cancer	0.000981	0.00102	CcSEcCtD
Paliperidone—Ill-defined disorder—Doxorubicin—muscle cancer	0.000974	0.00101	CcSEcCtD
Paliperidone—Nervous system disorder—Methotrexate—muscle cancer	0.00097	0.00101	CcSEcCtD
Paliperidone—Anaemia—Doxorubicin—muscle cancer	0.00097	0.00101	CcSEcCtD
Paliperidone—Thrombocytopenia—Methotrexate—muscle cancer	0.000968	0.00101	CcSEcCtD
Paliperidone—Agitation—Doxorubicin—muscle cancer	0.000964	0.001	CcSEcCtD
Paliperidone—Skin disorder—Methotrexate—muscle cancer	0.000961	0.000997	CcSEcCtD
Paliperidone—ADRA1A—renal system—muscle cancer	0.000948	0.0261	CbGeAlD
Paliperidone—Malaise—Doxorubicin—muscle cancer	0.000946	0.000982	CcSEcCtD
Paliperidone—Vertigo—Doxorubicin—muscle cancer	0.000943	0.000978	CcSEcCtD
Paliperidone—Anorexia—Methotrexate—muscle cancer	0.000943	0.000978	CcSEcCtD
Paliperidone—Syncope—Doxorubicin—muscle cancer	0.000941	0.000977	CcSEcCtD
Paliperidone—Leukopenia—Doxorubicin—muscle cancer	0.000939	0.000975	CcSEcCtD
Paliperidone—Palpitations—Doxorubicin—muscle cancer	0.000927	0.000962	CcSEcCtD
Paliperidone—Hypotension—Methotrexate—muscle cancer	0.000924	0.000959	CcSEcCtD
Paliperidone—Loss of consciousness—Doxorubicin—muscle cancer	0.000922	0.000957	CcSEcCtD
Paliperidone—Cough—Doxorubicin—muscle cancer	0.000916	0.00095	CcSEcCtD
Paliperidone—Convulsion—Doxorubicin—muscle cancer	0.000909	0.000944	CcSEcCtD
Paliperidone—Hypertension—Doxorubicin—muscle cancer	0.000906	0.00094	CcSEcCtD
Paliperidone—ADRA2C—renal system—muscle cancer	0.000903	0.0248	CbGeAlD
Paliperidone—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000901	0.000935	CcSEcCtD
Paliperidone—Insomnia—Methotrexate—muscle cancer	0.000895	0.000928	CcSEcCtD
Paliperidone—Myalgia—Doxorubicin—muscle cancer	0.000893	0.000927	CcSEcCtD
Paliperidone—Arthralgia—Doxorubicin—muscle cancer	0.000893	0.000927	CcSEcCtD
Paliperidone—Chest pain—Doxorubicin—muscle cancer	0.000893	0.000927	CcSEcCtD
Paliperidone—Anxiety—Doxorubicin—muscle cancer	0.00089	0.000924	CcSEcCtD
Paliperidone—Paraesthesia—Methotrexate—muscle cancer	0.000888	0.000922	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000887	0.000921	CcSEcCtD
Paliperidone—Discomfort—Doxorubicin—muscle cancer	0.000883	0.000916	CcSEcCtD
Paliperidone—Dyspnoea—Methotrexate—muscle cancer	0.000882	0.000915	CcSEcCtD
Paliperidone—Somnolence—Methotrexate—muscle cancer	0.000879	0.000913	CcSEcCtD
Paliperidone—Dry mouth—Doxorubicin—muscle cancer	0.000874	0.000907	CcSEcCtD
Paliperidone—Dyspepsia—Methotrexate—muscle cancer	0.000871	0.000904	CcSEcCtD
Paliperidone—Confusional state—Doxorubicin—muscle cancer	0.000864	0.000896	CcSEcCtD
Paliperidone—Decreased appetite—Methotrexate—muscle cancer	0.00086	0.000892	CcSEcCtD
Paliperidone—Anaphylactic shock—Doxorubicin—muscle cancer	0.000857	0.000889	CcSEcCtD
Paliperidone—Oedema—Doxorubicin—muscle cancer	0.000857	0.000889	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000854	0.000886	CcSEcCtD
Paliperidone—Fatigue—Methotrexate—muscle cancer	0.000853	0.000885	CcSEcCtD
Paliperidone—HTR1B—head—muscle cancer	0.000853	0.0234	CbGeAlD
Paliperidone—Infection—Doxorubicin—muscle cancer	0.000851	0.000883	CcSEcCtD
Paliperidone—Pain—Methotrexate—muscle cancer	0.000846	0.000878	CcSEcCtD
Paliperidone—Shock—Doxorubicin—muscle cancer	0.000843	0.000874	CcSEcCtD
Paliperidone—Nervous system disorder—Doxorubicin—muscle cancer	0.00084	0.000872	CcSEcCtD
Paliperidone—Thrombocytopenia—Doxorubicin—muscle cancer	0.000839	0.00087	CcSEcCtD
Paliperidone—Tachycardia—Doxorubicin—muscle cancer	0.000836	0.000867	CcSEcCtD
Paliperidone—Skin disorder—Doxorubicin—muscle cancer	0.000832	0.000863	CcSEcCtD
Paliperidone—HTR1D—head—muscle cancer	0.000826	0.0227	CbGeAlD
Paliperidone—HTR2C—head—muscle cancer	0.000817	0.0225	CbGeAlD
Paliperidone—Anorexia—Doxorubicin—muscle cancer	0.000816	0.000847	CcSEcCtD
Paliperidone—Feeling abnormal—Methotrexate—muscle cancer	0.000815	0.000846	CcSEcCtD
Paliperidone—HTR2A—embryo—muscle cancer	0.00081	0.0223	CbGeAlD
Paliperidone—ADRA2C—cardiac atrium—muscle cancer	0.000809	0.0222	CbGeAlD
Paliperidone—Gastrointestinal pain—Methotrexate—muscle cancer	0.000809	0.000839	CcSEcCtD
Paliperidone—Hypotension—Doxorubicin—muscle cancer	0.0008	0.000831	CcSEcCtD
Paliperidone—Urticaria—Methotrexate—muscle cancer	0.000786	0.000815	CcSEcCtD
Paliperidone—Abdominal pain—Methotrexate—muscle cancer	0.000782	0.000811	CcSEcCtD
Paliperidone—Body temperature increased—Methotrexate—muscle cancer	0.000782	0.000811	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00078	0.00081	CcSEcCtD
Paliperidone—Insomnia—Doxorubicin—muscle cancer	0.000775	0.000804	CcSEcCtD
Paliperidone—Paraesthesia—Doxorubicin—muscle cancer	0.000769	0.000798	CcSEcCtD
Paliperidone—Dyspnoea—Doxorubicin—muscle cancer	0.000764	0.000792	CcSEcCtD
Paliperidone—HRH1—smooth muscle tissue—muscle cancer	0.000762	0.021	CbGeAlD
Paliperidone—Somnolence—Doxorubicin—muscle cancer	0.000761	0.00079	CcSEcCtD
Paliperidone—CYP3A5—renal system—muscle cancer	0.000756	0.0208	CbGeAlD
Paliperidone—Dyspepsia—Doxorubicin—muscle cancer	0.000754	0.000782	CcSEcCtD
Paliperidone—Decreased appetite—Doxorubicin—muscle cancer	0.000745	0.000773	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000739	0.000767	CcSEcCtD
Paliperidone—Fatigue—Doxorubicin—muscle cancer	0.000738	0.000766	CcSEcCtD
Paliperidone—Pain—Doxorubicin—muscle cancer	0.000732	0.00076	CcSEcCtD
Paliperidone—Constipation—Doxorubicin—muscle cancer	0.000732	0.00076	CcSEcCtD
Paliperidone—Hypersensitivity—Methotrexate—muscle cancer	0.000729	0.000756	CcSEcCtD
Paliperidone—Asthenia—Methotrexate—muscle cancer	0.00071	0.000736	CcSEcCtD
Paliperidone—Feeling abnormal—Doxorubicin—muscle cancer	0.000706	0.000732	CcSEcCtD
Paliperidone—ADRA2C—tendon—muscle cancer	0.000705	0.0194	CbGeAlD
Paliperidone—Gastrointestinal pain—Doxorubicin—muscle cancer	0.0007	0.000727	CcSEcCtD
Paliperidone—Pruritus—Methotrexate—muscle cancer	0.0007	0.000726	CcSEcCtD
Paliperidone—HTR1A—head—muscle cancer	0.000688	0.0189	CbGeAlD
Paliperidone—Urticaria—Doxorubicin—muscle cancer	0.00068	0.000706	CcSEcCtD
Paliperidone—Abdominal pain—Doxorubicin—muscle cancer	0.000677	0.000703	CcSEcCtD
Paliperidone—Body temperature increased—Doxorubicin—muscle cancer	0.000677	0.000703	CcSEcCtD
Paliperidone—Diarrhoea—Methotrexate—muscle cancer	0.000677	0.000702	CcSEcCtD
Paliperidone—ADRA2C—vagina—muscle cancer	0.000654	0.018	CbGeAlD
Paliperidone—Dizziness—Methotrexate—muscle cancer	0.000654	0.000679	CcSEcCtD
Paliperidone—ADRA2A—cardiac atrium—muscle cancer	0.000646	0.0177	CbGeAlD
Paliperidone—HTR2A—smooth muscle tissue—muscle cancer	0.000637	0.0175	CbGeAlD
Paliperidone—ADRA1A—head—muscle cancer	0.000634	0.0174	CbGeAlD
Paliperidone—Hypersensitivity—Doxorubicin—muscle cancer	0.000631	0.000655	CcSEcCtD
Paliperidone—Vomiting—Methotrexate—muscle cancer	0.000629	0.000653	CcSEcCtD
Paliperidone—Rash—Methotrexate—muscle cancer	0.000624	0.000647	CcSEcCtD
Paliperidone—Dermatitis—Methotrexate—muscle cancer	0.000623	0.000647	CcSEcCtD
Paliperidone—DRD2—head—muscle cancer	0.000622	0.0171	CbGeAlD
Paliperidone—Headache—Methotrexate—muscle cancer	0.00062	0.000643	CcSEcCtD
Paliperidone—Asthenia—Doxorubicin—muscle cancer	0.000615	0.000638	CcSEcCtD
Paliperidone—HTR2A—renal system—muscle cancer	0.000613	0.0168	CbGeAlD
Paliperidone—Pruritus—Doxorubicin—muscle cancer	0.000606	0.000629	CcSEcCtD
Paliperidone—ADRA2C—head—muscle cancer	0.000604	0.0166	CbGeAlD
Paliperidone—DRD2—testis—muscle cancer	0.000601	0.0165	CbGeAlD
Paliperidone—Nausea—Methotrexate—muscle cancer	0.000588	0.00061	CcSEcCtD
Paliperidone—Diarrhoea—Doxorubicin—muscle cancer	0.000586	0.000608	CcSEcCtD
Paliperidone—ADRA2C—testis—muscle cancer	0.000584	0.016	CbGeAlD
Paliperidone—HRH1—tendon—muscle cancer	0.000573	0.0157	CbGeAlD
Paliperidone—CYP3A4—renal system—muscle cancer	0.000567	0.0156	CbGeAlD
Paliperidone—Dizziness—Doxorubicin—muscle cancer	0.000566	0.000588	CcSEcCtD
Paliperidone—ADRA2A—tendon—muscle cancer	0.000563	0.0155	CbGeAlD
Paliperidone—CYP2D6—renal system—muscle cancer	0.000558	0.0153	CbGeAlD
Paliperidone—CYP3A5—vagina—muscle cancer	0.000548	0.0151	CbGeAlD
Paliperidone—Vomiting—Doxorubicin—muscle cancer	0.000545	0.000565	CcSEcCtD
Paliperidone—Rash—Doxorubicin—muscle cancer	0.00054	0.00056	CcSEcCtD
Paliperidone—Dermatitis—Doxorubicin—muscle cancer	0.00054	0.00056	CcSEcCtD
Paliperidone—Headache—Doxorubicin—muscle cancer	0.000537	0.000557	CcSEcCtD
Paliperidone—HRH1—vagina—muscle cancer	0.000532	0.0146	CbGeAlD
Paliperidone—ADRA2A—vagina—muscle cancer	0.000522	0.0144	CbGeAlD
Paliperidone—Nausea—Doxorubicin—muscle cancer	0.000509	0.000528	CcSEcCtD
Paliperidone—HRH1—head—muscle cancer	0.000491	0.0135	CbGeAlD
Paliperidone—ADRA2A—head—muscle cancer	0.000482	0.0133	CbGeAlD
Paliperidone—HTR2A—tendon—muscle cancer	0.000478	0.0131	CbGeAlD
Paliperidone—HRH1—testis—muscle cancer	0.000474	0.013	CbGeAlD
Paliperidone—ADRA2A—testis—muscle cancer	0.000466	0.0128	CbGeAlD
Paliperidone—HTR2A—vagina—muscle cancer	0.000444	0.0122	CbGeAlD
Paliperidone—HTR2A—head—muscle cancer	0.00041	0.0113	CbGeAlD
Paliperidone—HTR2A—testis—muscle cancer	0.000396	0.0109	CbGeAlD
Paliperidone—CYP2D6—head—muscle cancer	0.000374	0.0103	CbGeAlD
Paliperidone—CYP2D6—testis—muscle cancer	0.000361	0.00992	CbGeAlD
